These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37966113)

  • 1. LAIR-1 agonism as a therapy for acute myeloid leukemia.
    Lovewell RR; Hong J; Kundu S; Fielder CM; Hu Q; Kim KW; Ramsey HE; Gorska AE; Fuller LS; Tian L; Kothari P; Paucarmayta A; Mason EF; Meza I; Manzanarez Y; Bosiacki J; Maloveste K; Mitchell N; Barbu EA; Morawski A; Maloveste S; Cusumano Z; Patel SJ; Savona MR; Langermann S; Myint H; Flies DB; Kim TK
    J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37966113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia: therapeutic targeting of stem cells.
    Pabon CM; Abbas HA; Konopleva M
    Expert Opin Ther Targets; 2022 Jun; 26(6):547-556. PubMed ID: 35634856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
    Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
    Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
    Kikushige Y; Miyamoto T
    Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
    de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
    Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.
    Wang H; Sica RA; Kaur G; Galbo PM; Jing Z; Nishimura CD; Ren X; Tanwar A; Etemad-Gilbertson B; Will B; Zheng D; Fooksman D; Zang X
    Nat Commun; 2024 Jan; 15(1):11. PubMed ID: 38167704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia.
    Laverdière I; Boileau M; Neumann AL; Frison H; Mitchell A; Ng SWK; Wang JCY; Minden MD; Eppert K
    Blood Cancer J; 2018 Jun; 8(6):52. PubMed ID: 29921955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways.
    Kikushige Y
    Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.
    Shingai Y; Yokota T; Okuzaki D; Sudo T; Ishibashi T; Doi Y; Ueda T; Ozawa T; Nakai R; Tanimura A; Ichii M; Shibayama H; Kanakura Y; Hosen N
    Stem Cells; 2021 Jun; 39(6):723-736. PubMed ID: 33539590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y; Miyamoto T
    Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells.
    Deslauriers AG; Kotini AG; Papapetrou EP
    Methods Mol Biol; 2021; 2185():411-422. PubMed ID: 33165864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
    Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway.
    Zhang Z; Li L; Wu C; Yin G; Zhu P; Zhou Y; Hong Y; Ni H; Qian Z; Wu WS
    Leukemia; 2020 Feb; 34(2):380-390. PubMed ID: 31492896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.